Tuesday, March 6, 2012

EMD Serono Collaborates with Lupus Research Institute to Sponsor Research with Promise for Developing New Treatments

A New Model of Collaboration Between the Pharmaceutical Industry and Patient Groups

Friday, February 17, 2012

Lupus Research Institute Applauds Formation of Congressional Lupus Caucus

Extends Support and Assistance through LRI’s Coalition of Lupus Advocacy Groups Nationwide

Wednesday, February 15, 2012

Lupus Research Institute Awards $3.6 Million for Novel Studies Driving Wide-Ranging New Science in Lupus

Thursday, January 12, 2012

Lupus Research Institute Launches Bold Global Research Initiative to Uncover the Root Causes of Lupus that Can Lead to a Cure

Call for Proposals for Distinguished Innovator Awards

Tuesday, December 27, 2011

2012 New Year’s Resolution: Stop Lupus in its Tracks

A Message from LRI Board Co-Chairmen Jack Lavery and Robert Ravitz

Friday, December 23, 2011

LRI Congratulates U.S. Congress for Passing Omnibus Bill HR 2055 Appropriating $1 Million to Lupus Medical Education

Legislation approved by White House Today Addresses Early Lupus Diagnosis and Treatment

Saturday, December 17, 2011

LRI Commends U.S. Congress for Meeting Urgent Need for Lupus Medical Training with $1 Million Appropriation in Omnibus Bill

Funding Aims to Improve Lupus Diagnosis and Treatment

Monday, November 21, 2011

S.L.E. Lupus Foundation Hosts “Life Without Lupus Gala 2011: A Night at the Museum”

Honoring U.S. Senator Frank Lautenberg & Mrs. Bonnie Englebardt Lautenberg, and Daniel J. Wallace, MD, Founder, Lupus LA

Tuesday, November 15, 2011

A Lupus Voice at the FDA

Tuesday, November 8, 2011

Epratuzumab Phase IIB Data Demonstrated Sensitivity of BICLA, a Novel BILAG-Based Composite Endpoint

ACR Presentation by Lupus LA founder Daniel Wallace, MD